Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 10944137

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2000 Aug
First author
Haioun C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2001 Mar 15;19(6):1884. doi: 10.1200/JCO.2001.19.6.1884.
    note
    Source null
    related pmid
    11251023
    relationship
    Comment in

Authors and identifiers

  1. name
    Haioun C
    type
    Author
  2. name
    Lepage E
    type
    Author
  3. name
    Gisselbrecht C
    type
    Author
  4. name
    Salles G
    type
    Author
  5. name
    Coiffier B
    type
    Author
  6. name
    Brice P
    type
    Author
  7. name
    Bosly A
    type
    Author
  8. name
    Morel P
    type
    Author
  9. name
    Nouvel C
    type
    Author
  10. name
    Tilly H
    type
    Author
  11. name
    Lederlin P
    type
    Author
  12. name
    Sebban C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Haioun C
    type
    Author
  2. name
    Lepage E
    type
    Author
  3. name
    Gisselbrecht C
    type
    Author
  4. name
    Salles G
    type
    Author
  5. name
    Coiffier B
    type
    Author
  6. name
    Brice P
    type
    Author
  7. name
    Bosly A
    type
    Author
  8. name
    Morel P
    type
    Author
  9. name
    Nouvel C
    type
    Author
  10. name
    Tilly H
    type
    Author
  11. name
    Lederlin P
    type
    Author
  12. name
    Sebban C
    type
    Author
bibliography ids
  1. nci-bib-6f0bca78b18f11150a0760b6
book metadata
content sha256
6682101d681988cf81fa347a1336f33f4eac6661bc741faefeda1df2f59fb74c
document type
citation
dois
  1. 10.1200/JCO.2000.18.16.3025
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:10944137
immutable id
pubmed:10944137@6682101d681988cf81fa347a1336f33f4eac6661bc741faefeda1df2f59fb74c
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
16
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3025-30
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2001 Mar 15;19(6):1884. doi: 10.1200/JCO.2001.19.6.1884.
    note
    Source null
    related pmid
    11251023
    relationship
    Comment in
outcomes validated
false
pmid
10944137
provenance
batch id
c98b220a79580c9840c7
provider
NCBI PubMed ESummary
record sha256
451dcf45cbd8b6fca1c548d1b4a0ec08e4e1ed085704cb14ce8f806c5e8c7fc4
response sha256
d5d875b1aa149faaecebc150cec3cacc2861402b103226e5006d2b0ce5dccd23
retrieved at
2026-09-09T23:45:37.924736+00:00
publication date
display
2000 Aug
precision
month
year
2000
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/10944137/
title
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

Preserved source evidence · Independent clinical review pending · Not medical advice